Rchr
J-GLOBAL ID:202001016397473384   Update date: Nov. 04, 2024

Shukuya Takehito

Shukuya Takehito
Research theme for competitive and other funds  (4):
  • 2024 - 2027 人工知能(AI)を用いた立体的・網羅的な肺癌病変自動計測システムの開発
  • 2022 - 2025 Developing a model to predict response to immune checkpoint inhibitor using machine learning
  • 2019 - 2021 Biomarker analysis for anti-PD-1/PD-L1 antibody with exosomal RNA/protein
  • 2013 - 2016 悪性胸膜中皮腫における新規バイオマーカー及び治療標的の探索
Papers (205):
  • Yoshihiro Masui, Takehito Shukuya, Shunichi Kataoka, Hitomi Shiozaki, Kana Kurokawa, Ikuko Nakamura, Taichi Miyawaki, Yoshika Koinuma, Tetsuhiko Asao, Ryota Kanemaru, et al. Second malignancy in advanced or recurrent non-small cell lung cancer after the advent of molecular targeted drugs and immunotherapy. Thoracic cancer. 2024
  • Keita Miura, Takehito Shukuya, Naoki Furuya, Ryo Morita, Akira Kisohara, Atsuto Mouri, Satoshi Watanabe, Hisashi Tanaka, Aya Hirata, Taiki Hakozaki, et al. Impact of Cachexia and First-Line Systemic Therapy for Previously Untreated Advanced Non-Small Cell Lung Cancer: NEJ050A. Journal of cachexia, sarcopenia and muscle. 2024
  • Keita Miura, Takehito Shukuya, Ray Greenstein, Ben Kaplan, Heather Wakelee, Kana Kurokawa, Kazuyuki Furuta, Shunsuke Kato, Junghee Suh, Smruthy Sivakumar, et al. Ancestry-, Sex-, and Age-Based Differences of Gene Alterations in NSCLC: From the Real-World Data of Cancer Genomic Profiling Tests. Journal of the National Comprehensive Cancer Network : JNCCN. 2024. 22. 7
  • Naohisa Matsumoto, Ken Tajima, Fumiyuki Takahashi, Yoichiro Mitsuishi, Aditya Wirawan, Moulid Hidayat, Wira Winardi, Adityo Wibowo, Daisuke Hayakawa, Kenta Izumi, et al. Clinical potential of SKP2 as diagnostic marker and therapeutic target in small cell lung cancer. Respiratory investigation. 2024. 62. 5. 901-909
  • Daichi Fujimoto, Hidetoshi Hayashi, Kenta Murotani, Yukihiro Toi, Toshihide Yokoyama, Terufumi Kato, Teppei Yamaguchi, Kaoru Tanaka, Satoru Miura, Motohiro Tamiya, et al. Prediction of prognosis in lung cancer using machine learning with inter-institutional generalizability: A multicenter cohort study (WJOG15121L: REAL-WIND). Lung cancer (Amsterdam, Netherlands). 2024. 194. 107896-107896
more...
MISC (109):
  • 永田 祐一, 関本 康人, 加藤 元康, 田中 志樹, 藤岡 進也, 荒井 雄太, 小松 亜里紗, 宿谷 威仁, 伊藤 潤, 田島 健, et al. 小児期から気道感染を繰り返し30歳代で嚢胞性線維症の確定診断に至った日本人兄弟例. 日本呼吸器学会誌. 2022. 11. 増刊. 300-300
  • 大熊智子, 三森友靖, 宿谷威仁, 増田孝一, 三浦啓太, 黒川加奈, 早川乃介, 徐仁美, 宮脇太一, 朝尾哲彦, et al. Retrospective study of steroid therapy to lung cancer patients with pneumonitis caused by immune checkpoint inhibitors (ICI). 日本呼吸器学会誌(Web). 2022. 11
  • 舛井嘉大, 宿谷威仁, 片岡峻一, 阿部瞳, 黒川加奈, 中村育子, 宮脇太一, 濃沼淑芳, 朝尾哲彦, 金丸良太, et al. 進行非小細胞肺癌の治療成績向上に伴い異次性二次癌がどのような影響を与えているか?. 日本肺癌学会学術集会号. 2022. 63rd (CD-ROM)
  • 永田 祐一, 宿谷 威仁, 三浦 啓太, 増田 孝一, Xu Shiting, 嶋村 尚子, 徐 仁美, 関本 康人, 朝尾 哲彦, 黒川 加奈, et al. 神経内分泌マーカーは小細胞肺癌において,化学療法の効果予測や予後予測に有用か?. 肺癌. 2021. 61. 6. 670-670
  • 中村 育子, 高阪 真路, 宿谷 威仁, 光石 陽一郎, 高橋 史行, 高橋 和久, 間野 博行. 胸水腫瘍細胞のシングルセル解析手法の開発. 肺癌. 2021. 61. 6. 764-764
more...
Awards (10):
  • 2021/11 - Asian pacific society of respirology JRS Young Scientific Award
  • 2018 - American Society of Clinical Oncology Merit Award
  • 2017 - The Ohio State Univeristy Pelotonia Postdoctoral Fellowship
  • 2017 - 日本肺癌学会 若手奨励賞
  • 2016 - 上原記念生命科学財団 リサーチフェローシップ
Show all
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page